Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer that has been confirmed by laboratory testing to be HER2-negative (a specific tumour type identified through tissue testing)
- People whose cancer has spread to the membranes surrounding the brain and spinal cord (called leptomeningeal metastases), confirmed either through a spinal fluid test or through scans combined with symptoms
- People aged 18 or older
Who may not be able to join:
- People whose blood test results show that the bone marrow, liver, or other organs are not functioning well enough to safely participate (specific blood count and liver function thresholds apply — confirm with trial site)
- People who have a known allergy to the study drugs or their ingredients
- People with a weakened immune system, such as those who are HIV-positive or have another immune deficiency condition
- People with other serious ongoing health conditions that could affect safe participation in the trial
- People who are pregnant or breastfeeding
- Women of childbearing age who are unwilling or unable to use effective contraception during the trial
- People who, for any other reason, the trial doctor considers unsuitable for participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenyu Pan, Huizhou Hospital of Guangzhou Medical University
Phone: +8618718178286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximal tolerated dose
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.